Anzeige
Mehr »
Login
Samstag, 25.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3C3BL | ISIN: US88642K1043 | Ticker-Symbol:
Branche
Immobilien
Aktienmarkt
Sonstige
1-Jahres-Chart
TIDEROCK COMPANIES INC Chart 1 Jahr
5-Tage-Chart
TIDEROCK COMPANIES INC 5-Tage-Chart
ACCESS Newswire
480 Leser
Artikel bewerten:
(2)

Tiderock Companies, Inc.: Tiderock Companies and MTAG Composites to Merge to Create Global Materials Company

Finanznachrichten News

BOSTON, MA / ACCESSWIRE / February 20, 2024 / Tiderock Companies, Inc. ("we", "our", or the "Company"), (OTC Pink:TDRK) is pleased to announce the signing of a Letter of Intent to acquire controlling interest of MTAG Composites LTD., a UK-based manufacturer renowned for its specialized molding solutions.

https://mtagcomposites.co.uk/

Established in 2008, MTAG Composites LTD, ("MTAG") has a solid footing in the European Marketplace, delivering a broad array of services across multiple sectors:

  • Rail
  • Automotive
  • Aerospace
  • Construction
  • Marine
  • Defense

MTAG is well-positioned to capitalize on the composites market's growth, which saw a valuation of USD $105.75 billion in 2022, and is expected to surge to USD $191.36 billion by 2032, growing at a CAGR of 6.1% from 2023 to 2032. For the fiscal year 2024, MTAG forecasts Gross Revenue of $12.5M USD, EBITDA of $3.0M USD and net income of $1.75M USD.

The purchase price of 90% of MTAG is £6.75M GBP (approximately $8.44M USD). The payment structure includes a promissory note of $1,250,000 USD, the issuance of 625,000 Series D Preferred Shares, and a reserve portion of the purchase price payable in cash and/or common stock at the Company's discretion after 12 months. New Series D Preferred shares, with a par value of $0.001, will have a stated value of $10 and can be converted into common stock at $0.20 per share, equating to 50 common shares for each share of Series D Preferred Stock. The transaction's closing is contingent upon satisfactory due diligence, definitive agreements and is slated to close by March 31, 2024.

Following the merger's completion, Tiderock Companies will operate under two primary divisions: manufacturing and real estate. MTAG shall lay the groundwork for the manufacturing efforts, extending its UK footprint to the United States and additional UK sites.Amidst a backdrop of stabilized interest rates and continued housing demand in targeted US markets, the Real Estate division, under the Sora brand, continues to develop unique commercial properties. The Company has discontinued activities related to the previously contemplated solar joint venture.

About Tiderock Companies, Inc.: Tiderock Companies is a diversified investment and advisory services company, specializing on real estate, land development, infrastructure, and private equity. With over 20 years of real estate experience, the Company specializes in land development, mixed-use real estate development, project management and public-private partnerships. Tiderock Companies, Inc. (OTC Pink:TDRK) is headquartered in Boston, MA., and can be contacted at www.tiderockcompanies.com or by phone at (800) 791-8433.

About MTAG Composites, LTD.: Established in 2008, MTAG Composites https://mtagcomposites.co.uk/ specializes in the manufacture of high quality Phenolic, Epoxy and Polyester Glass Fiber and Carbon Fiber reinforced plastic moldings with a diverse product mix for customers within the aerospace, automotive, marine, rail and construction industries. MTAG manufacturing facilities consist of over 61,000 sq ft based at Coningsby, Lincolnshire UK and employ over 120 employees.

Notice Regarding Forward-Looking Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations, or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate.

For more information:
Tiderock Companies, Inc.
53 State Street, Suite 500
Boston, MA 02109

Thomas B. Fore, CEO
Email: info@tiderockcompanies.com
Phone: (800) 791-8433

SOURCE: Tiderock Companies, Inc.



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.